IGM-IFOM Joint Seminars – Paolo Miuri

The third event of the IGM-IFOM seminar series will be anticipated to February 12nd at 14:30.

The seminar will be held by Paolo Mauri on “Physical perturbations of the cell nucleus“.

CNR-EMBL Scientific Collaboration Meeting

On January 28th, 2021, a scientific meeting organized by the Department of Biomedical Sciences of the CNR and EMBL and entitled “EMBL – Europe’s Life Science Research Institution” will be held via Zoom platform.

The event will be in the form of a Zoom webinar which can be registered at the following link

After registration a confirmation email with the information you need to attend the webinar will be sent.

The event program can be downloaded at this link

IGM-IFOM Joint Seminars – Giovanni Maga

The second event of the IGM-IFOM seminar series will be anticipated to January 26th at 14:30 (see the attached flyer).

The seminar will be held by Giovanni Maga (Director of IGM-CNR) on “New players for old games: ribonucleotide excision repair and alternative lengthening of telomerases“

Pandemics: Coronavirus and beyond

IGM-IFOM Joint Seminars – Francesco Ferrari

IGM-IFOM seminar series is starting from tomorrow. These seminars aim at fostering a better knowledge of the research activities in IFOM and IGM further improving our interactions.

The first seminar by Francesco Ferrari on “From chromatin 3D organisation to transcription regulation” is tomorrow January 14th at 14:30

E-RARE TREAT-HGPS

05/10/2020 WEBINAR

On 5 October 2020 at 17:00, Dr. Andrea Carfì (Moderna – Cambridge USA) will hold the webinar titled:

“Rapid development of a mRNA vaccine against SARS-CoV-2: preclinical and early clinical data”.

The seminar organised by the Department of Biology and Biotechnology of the University of Pavia and the PhD in Biotechnology of IUSS Pavia will be on zoom after registration (max 300 participants)

 

 

26/09/2020 Conference on the World Alzheimer’s Day

World Dementia Day is celebrated all over the world in September to draw everyone’s attention to this disease which is far more widespread than cancer and heart disease and currently without a cure. On 26 September 2020 in Pavia, at the Salone degli Affreschi of the Borromeo College, the conference titled “Courage, let’s talk about dementia: the two faces of Alzheimer’s disease, the disease and the person” will be held.
With this conference the MONTH OF ALZHEIMER will be celebrated by bringing a contribution of knowledge and support to “those who have no more mind”,  their families and an acknowledgment to researchers who dedicate their lives to study the disease and seek a possible cure.

PROGRAM

When the cell loses control: understand cancer to defeat it

Giovanni Maga has written a new book entitled: “Quando la cellula perde il controllo: capire il cancro per sconfiggerlo” and edited by Zanichelli. This is a popular book on tumors, suitable for both high school students and university students or curious but not experts adults. The World Health Organization has estimated that in 2018 alone, over 35 million people worldwide have developed cancer. Nearly ten million have died as a result of the disease, making it the leading cause of death in the world. Today we know over 100 different types of cancer, but why are they so many? The answer is in the complex molecular basis at the root of the disease. It is precisely because of this complexity that finding a cure for cancer is one of the most difficult challenges facing modern medicine. Thanks to the knowledge on the molecular basis of cancer, today we can recognize cancer cells, trace their genetic identikit and choose personalized therapies. We can read DNA in search of mutations that cause cancer and develop drugs that only affect diseased cells. We act on our immune system and make it capable of recognizing and attacking tumors. We recruit viruses and bacteria to attack and kill cancer cells. Alternative treatments are a threat instead. Homeopathy, crystal therapy, miraculous diets based on shark cartilage or bicarbonate are deadly traps. Scientific research is the only safe investment to treat cancer.